Enveric Biosciences News - ENVB

Company Name	Stock Ticker Symbol	Market	Type
Enveric Biosciences Inc	ENVB	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.01	1.11%	0.91	18:53:54

Open Price	Low Price	High Price	Close Price	Prev Close
0.93	0.892	0.9448	0.895	0.90

more quote information »

Recent News

Date	Time	Source	Heading
3/26/2024	07:00	BW	Enveric Biosciences Reports Financial Results and Provides..
3/19/2024	07:00	BW	Enveric Biosciences Signs Non-Binding Term Sheets to Pursue..
3/12/2024	07:00	BW	Enveric Biosciences Announces New Patent Issuances..
3/11/2024	12:35	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
3/11/2024	08:00	EDGAR2	Form 8-K - Current report
2/29/2024	07:00	EDGAR2	Form 8-K - Current report
2/29/2024	07:00	BW	Enveric Biosciences Signs Non-Binding Term Sheets to Pursue..
2/26/2024	16:53	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/26/2024	16:47	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/26/2024	16:42	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/23/2024	08:00	BW	Enveric Biosciences Agrees to Sell Cancer-Targeting..
2/21/2024	08:05	EDGAR2	Form 8-K - Current report
2/21/2024	08:00	BW	Enveric Biosciences Unveils Library of Preclinical Compounds..
2/14/2024	15:36	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2/09/2024	08:05	EDGAR2	Form 8-K - Current report
2/06/2024	10:17	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/05/2024	17:09	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
1/24/2024	08:05	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
1/23/2024	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
1/11/2024	16:43	EDGAR2	Form S-3 - Registration statement under Securities Act of..
1/08/2024	16:42	EDGAR2	Form 8-K - Current report
1/03/2024	08:05	EDGAR2	Form 8-K - Current report
12/29/2023	16:43	EDGAR2	Form 8-K - Current report
12/29/2023	08:52	BW	Enveric Biosciences Announces Exercise of Warrants and..
12/28/2023	08:05	EDGAR2	Form 8-K - Current report
12/28/2023	08:00	BW	Enveric Biosciences Selects EB-003 as Lead Drug Candidate..
12/27/2023	08:05	EDGAR2	Form 8-K - Current report
12/27/2023	08:00	BW	Enveric Biosciences Reports Year End Progress for..
12/20/2023	08:00	BW	Enveric Biosciences to Participate in Biotech Showcase 2024..
12/06/2023	16:00	EDGAR2	Form 424B4 - Prospectus [Rule 424(b)(4)]
12/05/2023	08:05	EDGAR2	Form 8-K - Current report
12/05/2023	08:00	BW	Enveric Biosciences Selects Development Candidates from..
12/01/2023	16:31	EDGAR2	Form S-1/A - General form for registration of securities..
11/29/2023	08:18	EDGAR2	Form 8-K - Current report
11/29/2023	08:00	BW	Enveric Biosciences Receives Notice of Allowance from USPTO..
11/27/2023	08:00	BW	Enveric Biosciences Announces Manuscript Describing the..
11/24/2023	08:00	BW	Enveric Biosciences Announces Presentation of Two Posters at..
11/22/2023	16:30	EDGAR2	Form 8-K - Current report
11/13/2023	16:10	EDGAR2	Form 8-K - Current report
11/13/2023	16:06	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/2023	16:01	BW	Enveric Biosciences Reports Third Quarter 2023 Corporate and..
11/06/2023	08:05	EDGAR2	Form 8-K - Current report
11/02/2023	17:29	EDGAR2	Form 8-K - Current report
10/31/2023	08:05	EDGAR2	Form 8-K - Current report
10/31/2023	08:00	BW	Enveric Biosciences Receives Notice of Allowance from USPTO..
10/20/2023	08:05	EDGAR2	Form 8-K - Current report
10/20/2023	08:00	BW	Enveric Biosciences to Present at the Centurion One 5th..
10/18/2023	08:05	EDGAR2	Form 8-K - Current report
10/18/2023	08:00	BW	Enveric Biosciences Initiates GLP Toxicology & Safety..
10/11/2023	08:05	EDGAR2	Form 8-K - Current report